Article Details
Retrieved on: 2018-11-05 03:31:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>ResMed (NYSE: RMD) has agreed to pay $750 million to acquire privately held MatrixCare, a provider of U.S. long-term post-acute care software, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here